Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease
Farsad Afshinnia(University of Michigan), Raymond R. Townsend(University of Pennsylvania), Harold I. Feldman(University of Pennsylvania), George Michailidis(University of Michigan), Eugene P. Rhee(Mass General Brigham), Alan S. Go(Kaiser Permanente), Jaeman Byun(University of Michigan), Michael J. Fischer(Edward Hines, Jr. VA Hospital), Lawrence J. Appel(Johns Hopkins University), Stefanie Wernisch(University of Michigan), James P. Lash(University of Illinois Chicago), Rajat Deo, Edgar R. Miller(Johns Hopkins University), Subramaniam Pennathur(University of Michigan), Panduranga S. Rao, Kumar Sharma(The University of Texas at San Antonio Health Science Center), Jing Chen(Tulane University), Jiang He(Southwestern Medical Center), John W. Kusek(National Institute of Diabetes and Digestive and Kidney Diseases), Lixia Zeng(University of Michigan–Ann Arbor), L. Lee Hamm(Korea Advanced Institute of Science and Technology), Mahboob Rahman(FIND)
Cited by 33
Related Papers
A New Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2009|25.7k
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k